Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
VisionWave Holdings, Inc. entered into an At The Market (ATM) Issuance Sales Agreement with Aegis Capital Corp. to establish a facility for the potential sale of up to $30 million of common stock. As of the filing date, no shares have been sold, and the company is not obligated to make any sales under the agreement.
Rivernorth Opportunities Fund Capital Raise of $75M
RiverNorth Opportunities Fund, Inc. completed a private placement of 3,000,000 shares of Series B Mandatory Redeemable Preferred Stock, raising $75 million in gross proceeds. The shares carry a 6.476% annual dividend rate and are due for mandatory redemption in September 2031. The fund intends to use the proceeds to refinance existing debt and make new portfolio investments.
PodcastOne Insider D. Jonathan Merriman Buys $17.7K of Stock
D. Jonathan Merriman bought 7,700 shares of PodcastOne, Inc. at $2.30 a share, worth $17.7K in total on Sep 16, 2026. Shares held after the trade: 361,432 (+2.2%).
Liberty Latin America Insider John C. Malone Buys $754K of Stock
John C. Malone bought 36,914 shares of Liberty Latin America Ltd. at $20.43 a share, worth $754K in total on Sep 16, 2026. Shares held after the trade: 1,388,040 (+2.7%).
BCB Bancorp, Inc. closed a public offering of 12,650,000 shares of common stock, which included the full exercise of the underwriter's over-allotment option. The offering generated aggregate gross proceeds of approximately $98 million at a price of $7.75 per share. The company intends to use the net proceeds for general corporate purposes, including maintaining liquidity and supporting bank capital in connection with the expected disposition of problem loans.
Block Insider Anthony Mathew Eisen Sells $1.4M of Stock
Anthony Mathew Eisen sold 18,000 shares of Block, Inc. at $76.55 to $78.36 a share (average $77.63) in 3 transactions, worth $1.4M in total between Sep 16, 2026 and Sep 18, 2026. Shares held after the trade: 1,380,672 (-0.4%).
HWH International Inc. has filed a charter amendment to change its corporate name to EnerSyn Global Inc., effective September 18, 2026. Starting September 22, 2026, the company's common stock will trade on the Nasdaq Capital Market under the new ticker symbol ESYN.
ATN International 10% Owner Cornelius B. Prior Jr. Sells $308K of Stock
Cornelius B. Prior Jr., 10% Owner, sold 9,867 shares of ATN International, Inc. at $31.03 to $31.32 a share (average $31.19) in 2 transactions, worth $308K in total between Aug 7, 2026 and Aug 21, 2026. Shares held after the trade: 20,174 (-21.0%).
Daktronics reported the results of its 2026 Annual Meeting of Stockholders, where shareholders elected two directors, approved executive compensation on an advisory basis, and ratified Deloitte & Touche LLP as the independent auditor for fiscal 2027. Additionally, the Board approved an increase in base salary to $1.2 million and a $170,000 RSU grant for Acting CFO Howard Atkins.
PTC Therapeutics Director Michael Schmertzler Sells $1.35M of Stock
Michael Schmertzler, Director, sold 20,000 shares of PTC Therapeutics, Inc. at $66.58 to $68.45 a share (average $67.49) in 4 transactions, worth $1.35M in total between Sep 16, 2026 and Sep 17, 2026. Shares held after the trade: 1,296,594 (-0.0%).
CleanSpark's subsidiary, CSDC Finance I, LLC, priced a $2.276 billion offering of 7.875% senior secured notes due 2031. The proceeds will be used to finance the remaining build-out of the Sandersville Facility data center, reimburse prior equity contributions, and fund debt service reserves.
Pagaya Technologies Insider Tami Rosen Sells $173K of Stock
Tami Rosen sold 8,504 shares of Pagaya Technologies Ltd. at $20.38 a share, worth $173K in total on Sep 18, 2026. Shares held after the trade: 15,400 (-35.6%).
Theravance Biopharma shareholders approved the company's acquisition by Zymeworks Inc. at an extraordinary general meeting. Under the terms of the merger agreement, Theravance will become a wholly owned subsidiary of Zymeworks. The approval included the merger plan, the contingent value rights agreement, and related corporate restructuring.
Q/C Technologies appointed Dr. Yossef Ehrlichman as Chief Technology Officer and entered into an amended employment agreement. The agreement includes an annual base salary of $275,000 and a restricted stock award with a grant date fair market value of $250,000, subject to stockholder approval of a share reserve increase. Dr. Ehrlichman previously served as the company's Founding Manager of Photonic Integrated Circuit Development.
5C Lending Partners 10% Owner LIBERTY MUTUAL HOLDING Co INC. Buys $9.76M of Stock
LIBERTY MUTUAL HOLDING Co INC., 10% Owner, bought 398,774 shares of 5C Lending Partners Corp. at $24.48 a share, worth $9.76M in total on Sep 17, 2026. Shares held after the trade: 4,182,050 (+10.5%).
CDT Equity $2.13M Debt Financing with J.J. Astor & Co.
CDT Equity Inc. issued a $2.13 million senior secured convertible promissory note to J.J. Astor & Co., receiving net proceeds of approximately $1.5 million. The note matures in March 2027 and is secured by a first priority lien on company assets, with repayment supported by proceeds from the company's existing at-the-market offering program. In connection with the debt, the company also issued warrants to purchase approximately 3.47 million shares of common stock at $0.25 per share.
Nvidia EVP & CFO Colette Kress Sells $7.65M of Stock
Colette Kress, EVP & CFO, sold 34,918 shares of Nvidia Corp at $218.01 to $219.59 a share (average $219.05) in 3 transactions, worth $7.65M in total on Sep 17, 2026. Shares held after the trade: 765,103 (-1.3%).
InMed Pharmaceuticals received a deficiency notice from Nasdaq for failing to maintain the minimum $2.5 million shareholders' equity requirement for continued listing. The company reported shareholders' equity of $1,075,007, largely due to expenses related to its pending merger with Mentari Therapeutics. InMed expects to regain compliance upon the closing of the merger, which is anticipated to bring approximately $490 million in gross proceeds to the combined company.
Paul V. Goode resigned from the Board of Directors of Glucotrack, Inc. effective September 14, 2026. Mr. Goode cited a potential conflict of interest between the company and its subsidiary regarding the implementation of duties and rights under a prior merger agreement with Lokahi Therapeutics, Inc.
Metropolitan Bank Holding Director Dale C. Fredston Sells $178K of Stock
Dale C. Fredston, Director, sold 2,000 shares of Metropolitan Bank Holding Corp. at $89.09 a share, worth $178K in total on Sep 17, 2026. Shares held after the trade: 14,668 (-12.0%).
Atossa Therapeutics made available an updated corporate and investor presentation on September 18, 2026, highlighting its clinical development strategy for (Z)-Endoxifen. The presentation covers the company's oncology core and rare disease expansion, including Phase 2 progress in breast cancer and regulatory designations for McCune-Albright Syndrome and Duchenne Muscular Dystrophy.
Civista Bancshares announced its participation in the Stephens 16th Annual Bank Forum on September 23-24, 2026, in Little Rock, Arkansas. The company furnished its Q2 2026 Investor Presentation, highlighting its $4.3 billion asset base, 1.34% ROAA, and strategic leadership transition under new CEO Chuck Parcher.
IT Tech Packaging, Inc. reported that its independent registered public accounting firm, HCL, PLLC, resigned effective September 16, 2026, only two weeks after being engaged. No audit reports had been issued and no disagreements on accounting principles or practices were reported during the brief engagement period. The company is currently seeking a successor auditor to complete its fiscal year 2025 financial statement audit.
Change Agents Debt Financing Update with certain accredited investors
Change Agents Corporation issued $280,000 in aggregate principal amount of original issue discount (OID) promissory notes maturing in April 2027. The notes carry a 7% annual interest rate and were issued for gross proceeds of $250,000, which will be used to repay existing debt and for working capital. As an inducement, the company also issued pre-funded warrants to purchase 100,000 shares of common stock.
Moleculin Biotech received a Staff Determination Letter from Nasdaq notifying the company that its common stock failed to maintain the $1.00 minimum bid price for 30 consecutive business days. Because the company already performed a reverse stock split within the last year, it is ineligible for the standard 180-day grace period and faces immediate delisting unless it successfully appeals to the Nasdaq Hearings Panel.
BPGC Acquisition Corp. shareholders approved an amendment to extend the deadline for completing a business combination from September 16, 2026, to March 16, 2028. In connection with the vote, holders of 22,566 Class A ordinary shares exercised their redemption rights at a price of approximately $12.22 per share, totaling roughly $0.28 million.
Fusemachines Inc. received a deficiency notice from Nasdaq on September 18, 2026, because its common stock closing bid price remained below $1.00 for 30 consecutive business days. The company has 180 calendar days, or until March 17, 2027, to regain compliance by maintaining a bid price of at least $1.00 for 10 consecutive business days.
Eastern International CEO Albert Wong Buys $200K of Stock
Albert Wong, CEO, bought 200,000 shares of Eastern International Ltd. at $1.00 a share, worth $200K in total on Aug 27, 2026. Shares held after the trade: 200,000.
RTB Digital Partnership with Paradium.AI, Inc. Worth $1B
RTB Digital signed a ten-year Strategic Platform Agreement with Paradium.AI to migrate Paradium's premium media brands and associated revenue to RTB's AI-powered digital media and business operations platform. The partnership is expected to generate approximately $100 million in annual gross revenue and $1 billion over the ten-year term through a revenue-sharing model. RTB will provide full-stack services including publishing, advertising, and DeFi-driven payments while Paradium grants RTB certain technology licenses and operational resources.
Lennox International approved a new form of Long-Term Incentive Award Agreement for U.S. employees at the Vice President level and above under its 2019 Equity and Incentive Compensation Plan. The updated agreement, which covers restricted stock units, performance share units, and stock appreciation rights, includes revised vesting and exercise schedules and retirement eligibility terms.